header
January 28, 2019

In This Issue
IN THE SPOTLIGHT
MMA's Gordon Smith Named Maine's Director of Opioid Response
AMA Outlines Policy Proposals to Combat Prescription Drug Price Increases
Researchers Say Outpatient Use of Benzodiazepines Increasing
AMA Survey of States: Top Issues Facing Organized Medicine this Year
New Moves by FDA Could Increase Naloxone Access
More Information About the Origins of the Opioid Problem
Medicare-for-all plans: How Do They Compare?
PCSS Offers Free On-line 8-hour X-waiver Course for MAT
129th MAINE LEGISLATURE
MMA Legislative Call Tuesday, January 29th
Report from the State House
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Webinar Presented by Baystate Financial - Sources of Retirement Income
Enrollment Underway for Maine’s Physician Executive Leadership Institute - The Advanced Course - Deadline: January 30, 2019
Identifying Substance Use Early Saves Lives! - SBIRT with Motivational Interviewing Training - 1-day Sessions Offered on Feb 2, Mar 2, Apr 6
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Psychiatric Mental Health NP - Leeds
Urgent Care Physician - South Portland, ME
PCHC in need of Pediatrician at Multiple Locations!
Outpatient Internal Medicine Physician – Bangor, Maine
Full-time Board Certified/Board Eligible MD/DO
Outpatient Family Medicine - Brunswick, Maine
Psychiatric Nurse Practitioner - Nasson Health Care
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health

 
Search Back Issues





 




Follow Us:
PCSS Offers Free On-line 8-hour X-waiver Course for MAT

Target Audience: Physicians who wish to apply for a waiver to prescribe buprenorphine.  

 Educational Objectives: At the conclusion of this activity, learners should be able to:

Review addiction identification and evidence-based treatments.

  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient. 
  • Explain the process of buprenorphine induction as well as stabilization and maintenance. 
  • Discuss other approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentially.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.  
  • Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.

  Fee: No cost

 Accreditation Statement: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians.

 Designation Statement: American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©